Noroo Paint (090350) 🔎 In-depth
KOSPI · Price as of 2026-08-06 · Updated 2026-08-09
Noroo Paint is a chemicals company that makes and sells architectural coatings and industrial coatings for automobiles, electronics, ships and industrial equipment, with the trait that once a customer relationship is secured it turns into repeat supply. Last year's annual results were revenue of ₩771.1 billion, operating profit of ₩30.2 billion and net profit of ₩16.5 billion, and in Q1 2026 a margin recovery of +70% operating profit and +103% net profit appeared, while in May it also signed a supply contract worth ₩81.6 billion. What stands out recently is that if the recovery continues quarter by quarter, the ₩81.6 billion contract settles into revenue, and construction and manufacturing utilization hold up, the low valuation of a 0.34x P/B and a 5.7% dividend comes into focus alongside the earnings recovery; on the other hand, if downstream industries slow again or raw-material costs rise once more, the pace of the margin recovery could be delayed.
This page organises public market and filing data for information purposes. It is not a recommendation to buy or sell, nor investment advice. Metrics labelled “forward” are our own unverified estimates. Please verify with the original DART filings and decide at your own responsibility.
30-second brief
Pulled directly from the computed values below — not a separately written opinion.
What do the SourceComputedEstimateReading tags mean?
Source filings and exchange data · Computed calculated from public data · Estimate our own unverified projection · Reading drafted automatically, then rule-checked. See AI & Automation.
Core valuation metric
This stock's effective sub-sector is “Coatings & Paints” (Chemicals, Refining, Steel & Materials · Chemicals), a type typically read first through P/E.
Paints and coatings are a chemical consumer product sold steadily into construction, autos, and industrial finishing, so revenue tends to flow reliably into current-year profit. With earnings relatively stable, price-to-earnings (P/E) is the natural first lens.
Price against earnings alone becomes unstable when earnings swing. Reading it together with price against assets helps gauge the downside.
This note explains how each sector is typically valued and is educational context only, not investment advice.
At-a-glance assessment financial health · growth · profitability · valuation
- Debt ratio, current ratio and interest burden all look healthy.
- Revenue fell 2.9% year over year (3-year trend: mixed).
- Most recent quarter (Q1 2026) revenue was 2.4% higher than a year earlier.
- ROE is 4.8% (controlling-interest basis). It is above the sector average.
- Operating margin is 4.3%.
- The P/E sits below the sector median.
Ownership & governance As of 2025-12-31
Largest shareholder Noroo Holdings 50.5% (corporate)
Controlling bloc incl. related parties 52.15%
With the controlling bloc holding 52%, control is very secure but the free float is thin.
🔎 In-depth analysis Reading
Noroo Paint is a chemicals company that makes and sells paints and coatings. Architectural coatings applied inside and outside buildings and industrial coatings used on automobiles, electronics, ships and industrial equipment are the center of revenue, and it has broadened into a range of industrial coatings such as those for furniture and flooring. Demand for coatings rises and falls with the construction cycle and manufacturing utilization, but there is a trait that once a customer relationship is secured it turns into repeat supply. Recent annual revenue is about ₩771.1 billion, and the base of that revenue is steady supply rather than one-off orders.
The latest close is ₩7,660 and the market capitalization is ₩153.2 billion. The price sits above its 20-day moving average (₩7,454) and above its 60-day moving average (₩7,615). It holds above both its short- and medium-term moving averages, so the trend looks healthy. The RSI (a supplementary indicator that gauges the strength of gains versus losses over the past 14 days on a 0-100 scale) is 55.5, a neutral level. The one-month change is +2.4%, the three-month change is -10.2%, and the position relative to the 52-week high is -22.9%. Relative strength versus the KOSPI is 26 (on a 1-99 scale, converted from returns against the index over the past year with more weight on recent performance; higher means stronger than the market). It is stronger than roughly 26% of all stocks. Over the past three months it outpaced the index by 7.2%. Chart interpretation is best done alongside trading volume and the dates on which disclosures occur.
With recent annual revenue of ₩771.1 billion, operating profit of ₩30.2 billion and net profit of ₩16.5 billion, the operating margin is 3.9% and ROE (how much is earned in a year on equity) is 4.0%. The debt ratio (debt against equity) is 166.3%, but with a current ratio of 163% and interest coverage of 6.3x there is no difficulty covering interest and short-term debt, so the balance sheet is stable. On last year's results, P/E (how many times one year of earnings the price is) is 9.31x and P/B (how many times book value) is 0.37x. A P/B of 0.34x means the share price is set at one-third of the company's net assets, so it is very cheap relative to assets. P/E looking like the mid-single digits owes largely to earnings dipping temporarily last year; the forward P/E reflecting this year's earnings comes down and is a low, undervalued signal even against peers. The dividend yield is 5.7%, a hefty payout to collect while the price is depressed.
Revenue moved without much variation in the ₩730-790 billion range, but earnings dipped deeply once last year. That is where operating profit fell from ₩43.7 billion (2024) to ₩30.2 billion (2025) and net profit from ₩35.2 billion to ₩16.5 billion. What matters is that after hitting that bottom the direction turned this year. Q1 2026 revenue was ₩176.2 billion (+2.4%), while operating profit jumped to ₩7.9 billion (+70.0% year on year) and net profit to ₩6.9 billion (+102.9%). Revenue being similar while profit nearly doubled signals that raw-material cost pressure is easing and margins are returning to normal. This year's operating profit is around ₩48.2 billion and net profit around ₩30.6 billion, a sharp recovery from last year's bottom, and the forward P/E ties into this. Because this recovery comes from margins that were depressed last year finding their place again, it is more natural to read it as the starting point of margin normalization rather than a one-quarter flash.
On April 22, 2026 the company voluntarily disclosed a corporate-value-enhancement plan directly, a document in which it laid out how it intends to steer shareholder value and operations — so it can be seen as a rudder for dividend and capital policy. On May 15 it signed a single supply contract worth ₩81.6 billion. For a company with annual revenue in the ₩770 billion range this is not a small amount, and it is booked as revenue over the contract period, providing a support for results. On January 28, last year's results were confirmed by disclosure at annual revenue of ₩771.1 billion, operating profit of ₩30.2 billion and net profit of ₩16.5 billion. Reading this bottom result together with the Q1 rebound makes the direction of the recovery clearer.
Noroo Paint's strengths are clear. Beyond the trailing metrics that reflect last year's depressed earnings as they were, the margin recovery of +70% operating profit and +103% net profit in Q1 has already shown up in the numbers, and on this year's earnings a P/B of 0.34x is a cheap spot against peers on both assets and earnings. A 5.7% dividend and a stable balance sheet provide support too. If the recovery continues quarter by quarter, the ₩81.6 billion contract settles into revenue, and coating demand (construction and manufacturing utilization) holds up, it becomes a strong scenario in which the low valuation and the earnings recovery come into focus together. Conversely, if construction and downstream industries slow again or raw-material costs rise once more, the pace of the margin recovery could be delayed — a point to watch alongside. In sum, this is a stock at the start of a recovery, with earnings turning while depressed and cheap, where the durability of the recovery is the key.
🔎 Valuation vs peers Undervalued
Chemicals names close by market capitalization.
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| TK Chemical | 1.25x | 0.11x | 5.36% |
| iFamily SC | 6.59x | 1.31x | 17.69% |
| Purit | 8.35x | 1.15x | 15.23% |
Within chemicals, the public-data peer set nearest by market capitalization was looked at first. The current P/E (how many times one year of earnings the price is) is 9.31x and P/B (how many times book value) is 0.37x. That said, smaller-cap names are more affected by earnings swings and financing disclosures, so no conclusion was drawn from last year's confirmed-results metrics alone. The basis for the outlook box is a DART seasonality approximation.
Earnings outlook Estimate company-stated · verified
| Type | Period | Revenue | Operating profit | Net profit |
|---|---|---|---|---|
| This year | 2026 | ₩803.3 billion | ₩48.2 billion | ₩30.6 billion |
| Next quarter | Q2 2026 | ₩233.4 billion | ₩21.3 billion | ₩12.9 billion |
Price history Close · MA20 · MA60
The latest close is ₩7,660 and the market capitalization is ₩153.2 billion. The price sits above its 20-day moving average (₩7,454) and above its 60-day moving average (₩7,615). It holds above both its short- and medium-term moving averages, so the trend looks healthy. The RSI (a supplementary indicator that gauges the strength of gains versus losses over the past 14 days on a 0-100 scale) is 55.5, a neutral level. The one-month change is +2.4%, the three-month change is -10.2%, and the position relative to the 52-week high is -22.9%. Relative strength versus the KOSPI is 26 (on a 1-99 scale, converted from returns against the index over the past year with more weight on recent performance; higher means stronger than the market). It is stronger than roughly 26% of all stocks. Over the past three months it outpaced the index by 7.2%. Chart interpretation is best done alongside trading volume and the dates on which disclosures occur.
Relative performance stock vs index · start = 100
Excess return vs index · 3M +7.20% / 6M -25.84% / 12M -55.31%
Key metrics Computed vs sector median
Valuation
The P/E of 9.31x is below the sector median (14.15x). The P/B of 0.37x is below the sector median (0.90x). Both metrics are low versus peers, so the price is not expensive relative to earnings and assets. That said, this P/E is based on last year's (trailing) results. With recent quarterly earnings up sharply, the trailing P/E can look higher than it really is, so a precise read is best done on this year's expected (forward) earnings.
Enterprise value (EV)
EV = market cap + net debt. It reflects cash and debt, so it captures the real cost of the whole business that market cap alone misses; lower multiples are cheaper relative to earnings or sales.
Intrinsic value (DCF estimate) Estimate
Model output — not a price target. This is what the formula returns under the assumptions below, not a view on where the share price should go.
DCF (discounted cash flow) estimate — discount rate 9.8%, initial growth 4.0%→terminal 2.0%, 10-yr forecast, free-cash-flow basis. A reference range that shifts materially with assumptions.
Profitability & financials
Return on equity (ROE) is 4.8%, above the sector average (4.0%). The operating margin is 4.3%. The debt ratio is 70.5%, so the financial structure is stable.
Growth FY2025 · annual report (consolidated)
| Item | 2023 | 2024 | 2025 | YoY |
|---|---|---|---|---|
| Revenue | $548.2M | $557.7M | $541.7M | -2.87% ↓ slower |
| Operating profit | $29.7M | $30.7M | $21.2M | -30.88% ↓ slower |
| Net profit | $19.6M | $24.7M | $11.6M | -53.19% ↓ slower |
| 5-year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $513.5M | $529.2M | $548.2M | $557.7M | $541.7M |
| Operating profit | $17.9M | $18.3M | $29.7M | $30.7M | $21.2M |
| Net profit | $10.1M | $8.1M | $19.6M | $24.7M | $11.6M |
| Revenue CAGR | 4-yr avg 1.34% | ||||
Revenue fell 2.9% year over year (2023 ₩780.4 billion → 2024 ₩793.8 billion → 2025 ₩771.1 billion), and the three-year trend is 'mixed'. The rate of decline widened from the prior year. Operating profit fell 30.9% year over year. The decline widened. Over the 5 years on record, revenue compound annual growth (CAGR) is 1.3%. The two-year revenue CAGR is -0.6%. In the most recent quarter (Q1 2026), revenue was 2.4% higher than the same period a year earlier.
Latest quarterly results Source Q1 2026 · vs year-ago
Technical indicators Computed
What stands out
- P/E and P/B are both low versus peers, so the price looks inexpensive relative to earnings and assets.
- The dividend yield, at 5.2%, is on the high side.
- The balance sheet is stable in terms of debt and liquidity.
Points to watch
- Revenue fell 2.9% year over year (3-year trend: mixed).
Recent news & events searched · sourced
- 2026-04-22UpdateCorporate-value-enhancement plan (voluntary disclosure): see the company's plan in the original textThis is planning material presented directly by the company. If it contains figures, treat it as a primary basis for the outlook box; if not, treat it as directional material only. Source
- 2026-05-15ContractSingle supply-contract signing: contract value ₩81.6 billionThe contract value and period are key to future revenue recognition. Whether it is one-off or a repeatable transaction shapes the medium-term reading. Source
- 2026-01-28EarningsChange of 30% or more (15% for large corporations) in revenue or profit structure: annual revenue ₩771.1 billion, operating profit ₩30.2 billion, net profit ₩16.5 billionThis is recent confirmed or preliminary results data. Check whether it runs in the same direction as the annual trend and whether any one-off factors are present. Source
Figure cross-check computed ↔ external
| Metric | Computed | External | Status | Source |
|---|---|---|---|---|
| Closing price | ₩7,660 | ₩7,660 | Confirmed | link |
| Latest quarterly results | revenue ₩176.2 billion, operating profit ₩7.9 billion | revenue ₩176.2 billion, operating profit ₩7.9 billion | Confirmed | link |
| Annual results | revenue ₩771.1 billion, operating profit ₩30.2 billion | revenue ₩771.1 billion, operating profit ₩30.2 billion | Confirmed | link |
| Outlook/plan disclosure text | — | — | Confirmed | link |
| Contract disclosure text | single supply contract signed: contract value ₩81.6 billion | single supply contract signed: contract value ₩81.6 billion | Confirmed | link |
| Results disclosure text | revenue or profit structure changed by 30% or more (15% for large companies): revenue ₩771.1 billion · operating profit ₩30.2 billion · net profit ₩16.5 billion | revenue or profit structure changed by 30% or more (15% for large companies): revenue ₩771.1 billion · operating profit ₩30.2 billion · net profit ₩16.5 billion | Confirmed | link |
| Outlook box basis | DART | DART | Confirmed | link |
Recent filings Source
- 2026-06-05OwnershipLargest-shareholder ownership change report
- 2026-06-01Corporate governance report
- 2026-05-15PeriodicQuarterly report
- 2026-05-15Single supply/sales contract
- 2026-04-22Disclosure
- 2026-03-20Disclosure
- 2026-03-20Disclosure
- 2026-03-20Shareholders' meeting notice
- 2026-03-12PeriodicAnnual business report
- 2026-03-12Audit report
- 2026-03-04Disclosure
- 2026-03-04Shareholders' meeting notice
📖 Plain-language glossary — expand if you are new to this
- P/E
- How many times a year's net profit the price is worth (lower is cheaper relative to earnings). The P/E here is on trailing (last full-year) results; for companies whose earnings swing fast (memory chips and other cyclicals/high-growth), a forward P/E on this year's expected earnings is more accurate.
- P/B
- Price relative to net assets (equity). Around 1x means it trades near book value; below 1x means below book.
- P/S
- Price relative to a year's revenue — useful for growth companies with thin earnings.
- Net debt / EV
- Net debt = interest-bearing debt − cash. Negative means more cash than debt (net cash). EV (enterprise value) = market cap + net debt, closer to what it would cost to buy the whole business.
- EV/EBIT · EV/EBITDA · EV/Sales
- Enterprise value against operating profit (EBIT), EBITDA, or revenue. Unlike P/E these reflect debt and cash; lower is cheaper relative to earnings power or sales.
- FCF / FCF yield
- Free cash flow = operating cash − capex, the cash actually left over. FCF yield = FCF ÷ market cap; higher means more cash generated per unit of market value.
- Intrinsic value (DCF)
- Future free cash flow (or, for some capex-heavy but profitable names, forecast earnings) discounted to today to estimate per-share value. Because it shifts a lot with the discount-rate and growth assumptions, it is shown as a bear/base/bull range, and the basis and assumptions are disclosed in one line beneath it.
- ROE
- How much profit the company earns in a year on its equity (%). Higher means better returns on capital.
- EPS / BPS
- Earnings per share / net assets (book value) per share.
- Operating / net margin
- Profit left from the core business / final profit after tax and interest, per unit of revenue.
- Debt ratio
- Debt relative to equity (%). Higher means more reliance on borrowing (norms vary by sector).
- Current ratio
- Assets convertible to cash within a year against debt due within a year. Above 100% leaves some short-term headroom.
- Interest coverage
- How many times operating profit covers the interest owed. Below 1x means operating profit alone struggles to cover interest.
- Dividend yield / payout ratio
- The year's dividend as a % of today's price / the share of earnings paid out as dividends.
- Revenue CAGR
- Multi-year growth expressed as a single yearly average (compound annual growth rate).
- RSI (short-term signal)
- Whether recent price action is overheated or beaten down. Above 70 is overbought, below 30 oversold.
- MA20 / MA60 (moving averages)
- The 20- and 60-day average price. Price above them signals a firmer short-term trend.
- vs 52-week high
- How far below the past year's peak the price sits now (%).
All figures are for reference only; how they read varies by sector and over time.
Sources: Korea FSC market-price API (data.go.kr), OpenDART, KRX/KIND — public data only.
Bong Stocks presents public-data-based information for reference only. It is not investment advice and contains no target prices, ratings, or buy/sell recommendations. Verify independently before making any decision.